Medicare Enrolled

Dr. Howard Braver, M.D.

Pulmonary Disease · Hollywood, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3700 WASHINGTON ST STE 200, Hollywood, FL 33021
9548943003
In practice since 2006 (19 years)
NPI: 1184672123 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Braver from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Braver? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Braver

Dr. Howard Braver is a pulmonary disease specialist in Hollywood, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Braver performed 1,843 Medicare services across 1,144 unique beneficiaries.

Between the years covered by Open Payments, Dr. Braver received a total of $13,104 from 68 pharmaceutical and/or device companies across 618 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Braver is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 34% volume in FL $13,104 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 61028 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
1,843
Medicare services
Top 34% in FL for pulmonary disease
1,144
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~97 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min) 737 $55 $150
Blood draw (venipuncture) 299 $5 $5
Office visit, established patient (30-39 min) 251 $82 $200
Test to measure expiratory airflow and volume changes before and after medication administration 123 $30 $200
Test to determine lung volumes using sensors 121 $43 $100
Test to examine how well the lungs exchange gases 121 $44 $150
Annual wellness visit, follow-up 79 $51 $250
New patient office visit (45-59 min) 55 $128 $200
Influenza vaccine, quadrivalent derived from cell cultures 17 $32 $35
Flu vaccine administration 17 $29 $30
Electrocardiogram (EKG), 12-lead 12 $12 $75
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use 11 $255 $260
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,104
Total received (2018-2024)
Avg $1,872/year across 7 years
Top 16% in FL for pulmonary disease
68
Companies
618
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,091 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,131
2023
$1,684
2022
$1,640
2021
$1,919
2020
$1,778
2019
$2,553
2018
$2,399

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$1,916
AstraZeneca Pharmaceuticals LP
$1,760
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,342
Mallinckrodt Hospital Products Inc.
$799
Mylan Specialty L.P.
$712
PFIZER INC.
$635
Mallinckrodt Enterprises LLC
$402
Mallinckrodt LLC
$397
Insmed, Inc.
$363
GENZYME CORPORATION
$338
Abbott Laboratories
$335
Janssen Pharmaceuticals, Inc
$328
Exeltis, USA Inc.
$203
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$199
Novo Nordisk Inc
$198
ANI Pharmaceuticals, Inc.
$194
AbbVie Inc.
$169
Amgen Inc.
$165
Lilly USA, LLC
$152
United Therapeutics Corporation
$144
Amarin Pharma Inc.
$138
Sunovion Pharmaceuticals Inc.
$137
Horizon Therapeutics plc
$124
Bayer Healthcare Pharmaceuticals Inc.
$107
Grifols USA, LLC
$102
IDORSIA PHARMACEUTICALS US INC
$94
Takeda Pharmaceuticals U.S.A., Inc.
$89
Phadia US Inc.
$84
JAZZ PHARMACEUTICALS INC.
$78
Actelion Pharmaceuticals US, Inc.
$75
Eisai Inc.
$75
E.R. Squibb & Sons, L.L.C.
$75
Inogen, Inc.
$73
Regeneron Healthcare Solutions, Inc.
$70
PORTOLA PHARMACEUTICALS, INC.
$70
Teva Pharmaceuticals USA, Inc.
$66
Merck Sharp & Dohme LLC
$61
ABBVIE INC.
$59
Shire North American Group Inc
$58
SANOFI-AVENTIS U.S. LLC
$55
Nabriva Therapeutics, plc
$53
Ironwood Pharmaceuticals, Inc
$46
Hologic Sales and Service, LLC
$39
Novartis Pharmaceuticals Corporation
$38
Advanced Respiratory, Inc
$37
Circassia Pharmaceuticals Inc
$33
Exact Sciences Corporation
$33
Bayer HealthCare Pharmaceuticals Inc.
$33
VBI Vaccine (Delaware) Inc.
$29
Biohaven Pharmaceuticals, Inc.
$27
Biohaven Pharmaceutical Holding Company Ltd.
$25
Medtronic MiniMed, Inc.
$25
Seqirus USA Inc
$19
Philips Electronics North America Corporation
$18
Acerus Pharmaceuticals Corporation
$18
Ethicon US, LLC
$17
Merck Sharp & Dohme Corporation
$16
Almatica Pharma LLC
$16
Pulmonx Corporation
$16
IBSA Pharma Inc.
$16
Mannkind Corporation
$15
Esperion Therapeutics, Inc.
$14
Medtronic, Inc.
$14
Nevro Corp.
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
CSL Behring
$13
Allergan, Inc.
$13
Hikma Pharmaceuticals USA
$12
Top 3 companies account for 38.3% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ADVAIR · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIMA · Adempas · Aimovig · Arikayce · ArmonAir Digihaler · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CHARTIS CATHETER · COLOGUARD · Cologuard Collection Kit · Confirm Rx · DUAKLIR PRESSAIR · DUPIXENT · DUZALLO · Dayvigo · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FASENRA · FLUCELVAX QUADRIVALENT · GARDASIL · GLASSIA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INTELLIS ADAPTIVESTIM · INVOKANA · ImmunoCAP · JARDIANCE · Kerendia · LINX Reflux Management System · LINZESS · LOREEV XR · Licart · Life 2000 Ventilation System · LifeVest · MOUNJARO · Minimed 630G · Mitigare · NEXLETOL · NUCALA · NURTEC ODT · Natesto · OFEV · OPSUMIT · Otezla · Ozempic · PENNSAID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · PreHevbrio · Prolastin-C · Prolastin-C Liquid · QULIPTA · QUVIVIQ · Rybelsus · SEEBRI · SHINGRIX · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Senza · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Volara System · Tresiba · UBRELVY · UPTRAVI · VIBERZI · VPRIV · Vascepa · Wegovy · XARELTO · XIFAXAN · XOLAIR · Xenleta · YUPELRI · Yupelri · ZEPBOUND · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $711 per 100 Medicare services performed
Looking for a pulmonary disease specialist in Hollywood?
Compare pulmonary diseases in the Hollywood area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
147
Per 100K population
7.6
County median income
$74,534
Nearest hospital
MEMORIAL REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Braver is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Braver experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Braver performed 737 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Braver receive payments from pharmaceutical companies?
Yes. Dr. Braver received a total of $13,104 from 68 companies across 618 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Braver's costs compare to other pulmonary diseases in Hollywood?
Dr. Braver's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Braver) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →